In vitro antimicrobial properties of Azidothymidine (AZT)

Acta Microbiologica et Immunologica Hungarica

Volumn 44, Issue 2, 1997, Pages 165-171

  Monno, Rosa ^a,b   Marcuccio, L ^a,b   Valenza, Maria Antonietta ^a,b   Leone, Emilia ^a,b   Bitetto, Candida ^a,b   Larocca, Angela ^a,b   Maggi, P ^a,b   Quarto, M ^a,b  

^a UNIVERSITY OF BARI   (Italy)

^b POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BACTERIUM; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; BACTERIA; HIV SEROPOSITIVITY; HUMANS; MICROBIAL SENSITIVITY TESTS; ZIDOVUDINE;

EID: 0030624696     PISSN: 12178950     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. St. Clair, M.H., Richards, C.A., Spector, T., Weinhold, K.J., Miller, W.H., Langlois, A.J., Furman, P.A.: 3′-azido-3′-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. Antimicrob Agents Chemother 31, 1972 (1987).
2. Elwell ,L.P., Ferone, R., Freeman, G.A, Fyfe, J.A., Hill, J.A., Ray, P.H., Richards, C.A., Singer, S.C., Knick, V.B., Rideout, J.L, Zimmerman, T.P.: Antibacterial activity and mechanism of action of 3′-azido-3′-deoxythymidine (BW A509U). Antimicrob Agents Chemother 31, 274 (1987).
3. Baron, E.J., Finegold, S.M.: Bailey & Scott's Diagnostic Microbiology, The C.V. Mosby Company, St. Louis. 1990. p. 171.
4. Fischl, M.A., Richman, D.D., Grieco, M.H., Gottlieb, M.S., Volberding, P.A., Laskin, O.L., Leedom, J.M., Groopman, J.E., Mildvan, D., Hirsh, M.S., Jackson, G.G., Drack, D.T., Nusinoff-Lehrman, S., and the AZT Collaborative Working Group: The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med 317, 185 (1987).
5. Saito, H., Tomioka, H.: Further studies on thymidine kinase distribution pattern of the enzyme in bacteria. J Gen Microbiol 130, 1863 (1984).
6. Keith, B.R., White, G., Wilson, H.R.: Efficacy of zidovudine (3′-azido-3′-deoxythymidine) in experimental gram-negative-bacterial infections. Antimicrob Agents Chemother 33, 479 (1989).
7. Lewin, C.S., Amyes, S.G.B.: Conditions required for the antibacterial activity of zidovudine. Eur J Clin Microbiol Infect Dis 8, 737 (1989).
8. Yarchoan, R., Klecker, R.W., Weinhold, J.J., Markam, P.D., Lyerly, H.K., Durack, D.T., Gelmann, E., Nusinoff-Lehrman, S., Blum, R.M., Barry, D.W., Shearer, G.M., Fischl, M.A., Mitsuya, H., Gallo, R.C., Collins, J.M., Bolognesi, D.P., Myers, C.E., Broder, S.: Administration of 3′-azido-3′-deoxythymidine, an inhibitor of HTLV-III/-LAV replication, to patients with AIDS or AIDS-related complex. Lancet i, 575 (1986).
9. Salmon, D., Detruchis, P., Leport, C., Bouvet, E., Karam, D., Meyohas, M.C., Coulaud, J.P., Vildé, J.L.: Efficacy of zidovudine in preventing relapses of Salmonella bacteremia in AIDS. J Infect Dis 163, 415 (1991).
10. Sperber, S.J., Feibusch, E.L., Damiani, A., Weinstein, M.P.: In vitro activities of nucleoside analog antiviral agents against Salmonellae. Antimicrob Agents Chemother 37, 106 (1993).
11. Herrmann, J.L., Lagrange, P.H.: Intracellular activity of zidovudine (3′-azido-3′-deoxythymidine, AZT) against Salmonella typhimurium in the macrophage cell line J 774-2. Antimicrob Agents Chemother 36, 1081 (1992).
12. Tocalli, L., Nardi, G., Tacchini, M.F., Lo Presti, S., Salvaggio, A.: Susceptibility to azidothymidine of strains of Salmonella isolated both from subjects with HIV-1 infection and from controls. J Preventive Med Hyg 34, 183 (1993).